{{Rsnum
|rsid=1124493
|Gene=DRD2
|Chromosome=11
|position=113411573
|Orientation=plus
|GMAF=0.4761
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=DRD2
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 40.7 | 50.4 | 8.8
| HCB | 21.9 | 46.7 | 31.4
| JPT | 23.9 | 48.7 | 27.4
| YRI | 10.9 | 34.7 | 54.4
| ASW | 17.5 | 54.4 | 28.1
| CHB | 21.9 | 46.7 | 31.4
| CHD | 17.6 | 56.5 | 25.9
| GIH | 31.7 | 52.5 | 15.8
| LWK | 2.7 | 39.1 | 58.2
| MEX | 53.4 | 39.7 | 6.9
| MKK | 7.7 | 41.0 | 51.3
| TSI | 54.9 | 39.2 | 5.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=21095016
|Title=Association of DRD2 and ANKK1 polymorphisms with prolactin increase in olanzapine-treated women
}}

{{PMID Auto
|PMID=19693267
|Title=Financial and psychological risk attitudes associated with two single nucleotide polymorphisms in the nicotine receptor (CHRNA4) gene.
|OA=1
}}

{{PMID Auto
|PMID=22893251
|Title=Influence of ANKK1 and DRD2 polymorphisms in response to haloperidol.
}}

{{on chip | Affy GenomeWide 6}}